Essex Bio-technology Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Public

  • Employees
  • 1,240

Employees

  • Stock Symbol
  • 01061

Stock Symbol

  • Investments
  • 6

  • Share Price
  • $0.26
  • (As of Friday Closing)

Essex Bio-technology General Information

Description

Essex Bio-Technology Ltd is principally engaged in investment holding and development, manufacture, and sale of biologic drugs in the People's Republic of China. The company is made up of segments of Ophthalmology products and Surgical products. Its products under Ophthalmology include the Beifushu series, Tobramycin Eye Drops, Levofloxacin Eye Drops, and Sodium Hyaluronate Eye Drops. The products under Surgical include the Beifuji series, Carisolv dental caries removal gel, and mouthwash. The majority of the group's revenue comes from the PRC, also operates in Hong Kong and other countries.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • Room 2818, China Merchants Tower
  • Shun Tak Centre, 168-200 Connaught Road Central
  • Hong Kong
  • Hong Kong
+852 2587
Primary Industry
Pharmaceuticals
Stock Exchange
HKG
Vertical(s)
Corporate Office
  • Room 2818, China Merchants Tower
  • Shun Tak Centre, 168-200 Connaught Road Central
  • Hong Kong
  • Hong Kong
+852 2587

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Essex Bio-technology Stock Performance

As of 13-Nov-2026, Essex Bio-technology’s stock price is $0.26. Its current market cap is $147M with 565M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.26 $0.25 $0.25 - $0.59 $147M 565M 210K $0.06

Essex Bio-technology Financials Summary

As of 30-Jun-2026, Essex Bio-technology has a trailing 12-month revenue of $220M.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 137,065 228,054 179,554 172,707
Revenue 220,421 232,650 213,990 221,858
EBITDA 54,338 60,701 54,594 51,699
Net Income 33,974 40,800 39,371 35,158
Total Assets 461,169 448,600 384,240 361,844
Total Debt 44,509 44,581 24,092 37,626
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Essex Bio-technology Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Essex Bio-Technology Ltd is principally engaged in investment holding and development, manufacture, and sale of biologic
Pharmaceuticals
Hong Kong, Hong Kong
1,240 As of 2026

Beijing, China
 

Vienna, Austria
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Essex Bio-technology Competitors (9)

One of Essex Bio-technology’s 9 competitors is Huonland, a Corporate Backed or Acquired company based in Beijing, China.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Huonland Corporate Backed or Acquired Beijing, China
Pfizer (Vienna) Corporation Vienna, Austria
Pfizer Pakistan Corporation Karachi, Pakistan
Taibang Biological Group Private Equity-Backed Beijing, China
Grifols Corporation Barcelona, Spain
You’re viewing 5 of 9 competitors. Get the full list »

Essex Bio-technology Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Essex Bio-technology Investments & Acquisitions (6)

Essex Bio-technology’s most recent deal was a Early Stage VC with CytoMed Therapeutics for . The deal was made on 18-Oct-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
CytoMed Therapeutics 18-Oct-2022 Early Stage VC Other Pharmaceuticals and Biotechnology
Wuhan Yadian Biotechnology 01-Apr-2019 Merger/Acquisition Other Devices and Supplies
DB Therapeutics 30-Oct-2018 Early Stage VC Medical Supplies
Mito.Tech 28-Aug-2018 Later Stage VC Drug Discovery
AC Immune 09-May-2016 Later Stage VC Drug Discovery
You’re viewing 5 of 6 investments and acquisitions. Get the full list »

Essex Bio-technology ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view Essex Bio-technology’s complete esg history, request access »

Essex Bio-technology Exits (2)

Essex Bio-technology’s most recent exit was on 09-May-2016 from AC Immune. The exit was categorized as with 3 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
AC Immune 09-May-2016 Completed
  • 3 buyers
Abpro 06-Apr-2016 Later Stage VC Completed
To view Essex Bio-technology’s complete exits history, request access »

Essex Bio-technology Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Wuhan Yadian Biotechnology Wuhan, China

Essex Bio-technology FAQs

  • When was Essex Bio-technology founded?

    Essex Bio-technology was founded in 2000.

  • Where is Essex Bio-technology headquartered?

    Essex Bio-technology is headquartered in Hong Kong, Hong Kong.

  • What is the size of Essex Bio-technology?

    Essex Bio-technology has 1,240 total employees.

  • What industry is Essex Bio-technology in?

    Essex Bio-technology’s primary industry is Pharmaceuticals.

  • Is Essex Bio-technology a private or public company?

    Essex Bio-technology is a Public company.

  • What is Essex Bio-technology’s stock symbol?

    The ticker symbol for Essex Bio-technology is 01061.

  • What is the current stock price of Essex Bio-technology?

    As of 13-Nov-2026 the stock price of Essex Bio-technology is $0.26.

  • What is the current market cap of Essex Bio-technology?

    The current market capitalization of Essex Bio-technology is $147M.

  • What is Essex Bio-technology’s current revenue?

    The trailing twelve month revenue for Essex Bio-technology is $220M.

  • Who are Essex Bio-technology’s competitors?

    Huonland, Pfizer (Vienna), Pfizer Pakistan, Taibang Biological Group, and Grifols are some of the 9 competitors of Essex Bio-technology.

  • What is Essex Bio-technology’s annual earnings per share (EPS)?

    Essex Bio-technology’s EPS for 12 months was $0.06.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process